A previous meta-analysis [10] of 12 studies (8 studies [14], [15], [16], [17], [18], [20], [21], [23] were included in our meta-analysis) was performed to analyze the difference in TR between IRI-administered cancer patients with different UGT1A1*28 genotypes. Here, UGT1A1 is linked to cancer.